Law firm investigates Select Medical merger over possible board breaches and unfair shareholder terms

Bleichmar Fonti & Auld LLP is investigating Select Medical Holdings Corporation's board and management for potential breaches of fiduciary duty related to the company's pending $16.50 per share sale. The merger involves insiders allowed to rollover shares, while public shareholders must accept cash, raising fairness concerns. The shareholder vote is set for June 26, 2026, with the merger expected to close soon after, possibly limiting further scrutiny. Current shareholders are urged to seek legal advice as the investigation continues.